Christopher Robert Sudfeld, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tanzania | 79 | 2024 | 1369 | 5.100 |
Why?
|
Child Development | 32 | 2024 | 2258 | 4.470 |
Why?
|
Micronutrients | 18 | 2022 | 378 | 4.110 |
Why?
|
Dietary Supplements | 44 | 2024 | 3370 | 3.710 |
Why?
|
HIV Infections | 42 | 2024 | 16984 | 2.900 |
Why?
|
Premature Birth | 15 | 2024 | 1742 | 2.590 |
Why?
|
Cholecalciferol | 5 | 2022 | 543 | 2.040 |
Why?
|
Vitamin D Deficiency | 9 | 2022 | 1368 | 1.930 |
Why?
|
Infant Mortality | 10 | 2023 | 747 | 1.560 |
Why?
|
Growth Disorders | 13 | 2024 | 625 | 1.490 |
Why?
|
Anemia, Iron-Deficiency | 8 | 2022 | 366 | 1.450 |
Why?
|
Mothers | 14 | 2023 | 2175 | 1.420 |
Why?
|
Tuberculosis, Pulmonary | 5 | 2020 | 821 | 1.400 |
Why?
|
Infant, Low Birth Weight | 7 | 2024 | 843 | 1.350 |
Why?
|
Nutritional Status | 12 | 2023 | 1596 | 1.340 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 3 | 2021 | 159 | 1.340 |
Why?
|
Malnutrition | 9 | 2024 | 633 | 1.310 |
Why?
|
Pregnancy | 59 | 2024 | 29441 | 1.290 |
Why?
|
Vitamins | 15 | 2022 | 1632 | 1.290 |
Why?
|
Maternal Nutritional Physiological Phenomena | 4 | 2020 | 383 | 1.270 |
Why?
|
Pregnancy Complications, Infectious | 8 | 2023 | 2095 | 1.270 |
Why?
|
Infant | 71 | 2024 | 35675 | 1.240 |
Why?
|
Rural Population | 19 | 2022 | 2239 | 1.190 |
Why?
|
Child Nutritional Physiological Phenomena | 5 | 2023 | 294 | 1.190 |
Why?
|
Motor Skills | 4 | 2019 | 518 | 1.160 |
Why?
|
Iron | 12 | 2024 | 1764 | 1.150 |
Why?
|
Vitamin A | 10 | 2022 | 612 | 1.150 |
Why?
|
Vitamin D | 12 | 2022 | 3273 | 1.130 |
Why?
|
Anti-Retroviral Agents | 5 | 2019 | 1766 | 1.120 |
Why?
|
Folic Acid | 8 | 2022 | 1299 | 1.110 |
Why?
|
Adolescent Development | 2 | 2021 | 280 | 1.100 |
Why?
|
Developing Countries | 17 | 2024 | 2819 | 1.080 |
Why?
|
Pregnancy Complications | 5 | 2023 | 2921 | 1.080 |
Why?
|
Depression | 11 | 2023 | 7921 | 1.020 |
Why?
|
Stillbirth | 6 | 2023 | 345 | 1.010 |
Why?
|
Infant, Newborn | 49 | 2024 | 25919 | 1.000 |
Why?
|
Poverty | 7 | 2021 | 2640 | 0.990 |
Why?
|
Birth Weight | 10 | 2023 | 2069 | 0.950 |
Why?
|
Calcium, Dietary | 3 | 2024 | 530 | 0.910 |
Why?
|
Thinness | 7 | 2023 | 489 | 0.900 |
Why?
|
Cognition | 12 | 2024 | 6849 | 0.880 |
Why?
|
Antiretroviral Therapy, Highly Active | 9 | 2024 | 1891 | 0.870 |
Why?
|
Child Nutrition Disorders | 2 | 2021 | 147 | 0.870 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 2 | 2022 | 52 | 0.850 |
Why?
|
Anemia | 10 | 2024 | 1495 | 0.850 |
Why?
|
Child, Preschool | 54 | 2024 | 41660 | 0.840 |
Why?
|
Breast Feeding | 10 | 2024 | 1348 | 0.840 |
Why?
|
HIV Wasting Syndrome | 2 | 2013 | 97 | 0.840 |
Why?
|
Zinc | 7 | 2024 | 688 | 0.790 |
Why?
|
Wasting Syndrome | 3 | 2021 | 99 | 0.790 |
Why?
|
Measles Vaccine | 2 | 2013 | 79 | 0.770 |
Why?
|
Intelligence | 3 | 2021 | 913 | 0.760 |
Why?
|
Female | 129 | 2024 | 386085 | 0.760 |
Why?
|
CD4 Lymphocyte Count | 9 | 2022 | 2556 | 0.760 |
Why?
|
Pregnancy Outcome | 8 | 2023 | 2864 | 0.750 |
Why?
|
Milk, Human | 4 | 2023 | 479 | 0.750 |
Why?
|
Pregnant Women | 5 | 2023 | 557 | 0.740 |
Why?
|
Infant, Small for Gestational Age | 7 | 2023 | 441 | 0.720 |
Why?
|
Prenatal Care | 4 | 2023 | 1104 | 0.720 |
Why?
|
Pre-Eclampsia | 3 | 2024 | 1204 | 0.700 |
Why?
|
Double-Blind Method | 18 | 2023 | 12328 | 0.700 |
Why?
|
Opportunistic Infections | 2 | 2013 | 377 | 0.690 |
Why?
|
Income | 4 | 2021 | 1864 | 0.670 |
Why?
|
Hypercalcemia | 1 | 2022 | 415 | 0.660 |
Why?
|
Unemployment | 2 | 2021 | 210 | 0.650 |
Why?
|
Education, Nonprofessional | 1 | 2018 | 31 | 0.630 |
Why?
|
Humans | 161 | 2024 | 752411 | 0.620 |
Why?
|
Lactation | 4 | 2022 | 391 | 0.600 |
Why?
|
Child | 54 | 2024 | 79004 | 0.600 |
Why?
|
Measles | 2 | 2010 | 183 | 0.600 |
Why?
|
Punishment | 1 | 2018 | 95 | 0.590 |
Why?
|
Viral Load | 7 | 2024 | 3285 | 0.580 |
Why?
|
Prospective Studies | 31 | 2024 | 53809 | 0.550 |
Why?
|
Pregnancy Trimester, Third | 1 | 2019 | 584 | 0.550 |
Why?
|
Health Status | 6 | 2020 | 4050 | 0.540 |
Why?
|
Anti-HIV Agents | 7 | 2024 | 4430 | 0.540 |
Why?
|
World Health Organization | 2 | 2019 | 1294 | 0.530 |
Why?
|
Alanine Transaminase | 1 | 2019 | 603 | 0.530 |
Why?
|
Diarrhea | 7 | 2024 | 1336 | 0.530 |
Why?
|
Nutrition Policy | 2 | 2019 | 473 | 0.520 |
Why?
|
Morbidity | 8 | 2024 | 1757 | 0.510 |
Why?
|
Executive Function | 2 | 2021 | 1351 | 0.500 |
Why?
|
Calcium | 4 | 2024 | 5699 | 0.500 |
Why?
|
Fetal Development | 1 | 2020 | 767 | 0.470 |
Why?
|
Tuberculosis | 4 | 2022 | 1988 | 0.470 |
Why?
|
Anthropometry | 5 | 2023 | 1342 | 0.470 |
Why?
|
Growth | 2 | 2016 | 366 | 0.460 |
Why?
|
Cross-Sectional Studies | 29 | 2024 | 25539 | 0.460 |
Why?
|
Gestational Age | 3 | 2021 | 3545 | 0.450 |
Why?
|
Aftercare | 4 | 2024 | 914 | 0.450 |
Why?
|
Adolescent | 37 | 2024 | 86766 | 0.440 |
Why?
|
Diet | 7 | 2021 | 7949 | 0.440 |
Why?
|
Mental Health | 4 | 2020 | 3149 | 0.440 |
Why?
|
Male | 80 | 2024 | 354908 | 0.440 |
Why?
|
Young Adult | 36 | 2024 | 57632 | 0.440 |
Why?
|
Social Support | 1 | 2023 | 2118 | 0.430 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2017 | 662 | 0.430 |
Why?
|
Adult | 59 | 2024 | 216927 | 0.430 |
Why?
|
Socioeconomic Factors | 15 | 2023 | 7747 | 0.430 |
Why?
|
Research | 1 | 2021 | 1962 | 0.430 |
Why?
|
Vitamin B 12 | 3 | 2020 | 517 | 0.410 |
Why?
|
Herpes Genitalis | 1 | 2013 | 142 | 0.400 |
Why?
|
India | 8 | 2024 | 2282 | 0.400 |
Why?
|
Antibodies, Viral | 2 | 2013 | 3106 | 0.400 |
Why?
|
Herpesvirus 2, Human | 1 | 2013 | 190 | 0.400 |
Why?
|
Ethiopia | 7 | 2022 | 450 | 0.390 |
Why?
|
Vitamin A Deficiency | 4 | 2017 | 89 | 0.390 |
Why?
|
Hemoglobins | 7 | 2022 | 1510 | 0.380 |
Why?
|
Patient Discharge | 5 | 2024 | 3412 | 0.380 |
Why?
|
Cohort Studies | 20 | 2024 | 40980 | 0.370 |
Why?
|
Selenium | 1 | 2014 | 414 | 0.370 |
Why?
|
Randomized Controlled Trials as Topic | 14 | 2024 | 10196 | 0.360 |
Why?
|
Patient Compliance | 1 | 2020 | 2679 | 0.340 |
Why?
|
Iron, Dietary | 2 | 2023 | 138 | 0.340 |
Why?
|
Serum Albumin | 1 | 2013 | 676 | 0.340 |
Why?
|
Infectious Disease Transmission, Vertical | 4 | 2022 | 1337 | 0.340 |
Why?
|
Prevalence | 15 | 2023 | 15508 | 0.330 |
Why?
|
Chickens | 2 | 2021 | 855 | 0.320 |
Why?
|
Infant Nutritional Physiological Phenomena | 4 | 2019 | 348 | 0.320 |
Why?
|
Risk Factors | 28 | 2024 | 73425 | 0.320 |
Why?
|
Disease Transmission, Infectious | 1 | 2014 | 558 | 0.310 |
Why?
|
Niger | 3 | 2022 | 38 | 0.310 |
Why?
|
Vaccination | 2 | 2022 | 3322 | 0.300 |
Why?
|
Health Promotion | 2 | 2019 | 2200 | 0.290 |
Why?
|
Peer Group | 1 | 2012 | 656 | 0.290 |
Why?
|
Weight Loss | 2 | 2022 | 2649 | 0.290 |
Why?
|
Brazil | 5 | 2021 | 1186 | 0.290 |
Why?
|
Fungi | 1 | 2009 | 332 | 0.280 |
Why?
|
Linear Models | 5 | 2021 | 5859 | 0.280 |
Why?
|
Mycoses | 1 | 2009 | 383 | 0.270 |
Why?
|
Body Height | 6 | 2024 | 1563 | 0.270 |
Why?
|
Developmental Disabilities | 3 | 2019 | 1510 | 0.270 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2022 | 512 | 0.260 |
Why?
|
Pakistan | 2 | 2023 | 298 | 0.260 |
Why?
|
RNA, Viral | 1 | 2014 | 2824 | 0.250 |
Why?
|
Malawi | 4 | 2024 | 298 | 0.250 |
Why?
|
Incidence | 10 | 2020 | 21157 | 0.240 |
Why?
|
Dysentery | 1 | 2024 | 14 | 0.240 |
Why?
|
Meconium Aspiration Syndrome | 1 | 2024 | 30 | 0.230 |
Why?
|
Animal Husbandry | 2 | 2021 | 64 | 0.230 |
Why?
|
Quality Improvement | 1 | 2019 | 3798 | 0.230 |
Why?
|
Age Factors | 11 | 2021 | 18298 | 0.220 |
Why?
|
Africa South of the Sahara | 6 | 2023 | 728 | 0.220 |
Why?
|
Liberia | 4 | 2024 | 167 | 0.220 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2019 | 2467 | 0.210 |
Why?
|
Placebos | 2 | 2020 | 1665 | 0.210 |
Why?
|
Maternal Age | 4 | 2019 | 800 | 0.210 |
Why?
|
Disease Progression | 3 | 2022 | 13405 | 0.200 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7400 | 0.200 |
Why?
|
Anxiety | 1 | 2017 | 4455 | 0.200 |
Why?
|
China | 4 | 2021 | 2337 | 0.200 |
Why?
|
Communication | 1 | 2015 | 3806 | 0.190 |
Why?
|
Clinical Protocols | 2 | 2017 | 1436 | 0.190 |
Why?
|
Health Behavior | 4 | 2020 | 2615 | 0.190 |
Why?
|
Models, Theoretical | 3 | 2021 | 3546 | 0.190 |
Why?
|
Nutritive Value | 2 | 2021 | 342 | 0.190 |
Why?
|
Peru | 3 | 2019 | 860 | 0.190 |
Why?
|
Sex Factors | 10 | 2022 | 10457 | 0.190 |
Why?
|
Treatment Outcome | 11 | 2022 | 64250 | 0.190 |
Why?
|
Education | 2 | 2021 | 537 | 0.180 |
Why?
|
Infant Nutrition Disorders | 2 | 2018 | 71 | 0.180 |
Why?
|
Antidiarrheals | 1 | 2020 | 46 | 0.180 |
Why?
|
Language Development | 2 | 2019 | 183 | 0.180 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2022 | 295 | 0.180 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 1261 | 0.180 |
Why?
|
Follow-Up Studies | 12 | 2022 | 39077 | 0.180 |
Why?
|
Educational Status | 2 | 2019 | 2499 | 0.180 |
Why?
|
Azithromycin | 1 | 2021 | 198 | 0.180 |
Why?
|
Armenia | 1 | 2020 | 15 | 0.180 |
Why?
|
Growth Hormone | 1 | 2022 | 566 | 0.180 |
Why?
|
BCG Vaccine | 1 | 2022 | 366 | 0.170 |
Why?
|
Survival Analysis | 3 | 2019 | 10172 | 0.170 |
Why?
|
Eggs | 1 | 2020 | 183 | 0.170 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14325 | 0.160 |
Why?
|
Maternal Behavior | 1 | 2021 | 302 | 0.160 |
Why?
|
Multivariate Analysis | 5 | 2017 | 12138 | 0.160 |
Why?
|
Immunoglobulins | 1 | 2022 | 865 | 0.160 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 418 | 0.160 |
Why?
|
Urban Population | 4 | 2021 | 2005 | 0.160 |
Why?
|
Hematologic Tests | 1 | 2020 | 236 | 0.160 |
Why?
|
Financial Support | 1 | 2019 | 115 | 0.160 |
Why?
|
Intelligence Tests | 1 | 2019 | 498 | 0.160 |
Why?
|
Administration, Oral | 3 | 2021 | 4002 | 0.160 |
Why?
|
Child Mortality | 2 | 2011 | 201 | 0.160 |
Why?
|
Drug Administration Schedule | 3 | 2021 | 4876 | 0.160 |
Why?
|
Vietnam | 1 | 2019 | 412 | 0.150 |
Why?
|
Quality of Life | 1 | 2020 | 13154 | 0.150 |
Why?
|
Time Factors | 5 | 2021 | 39846 | 0.150 |
Why?
|
Ferritins | 4 | 2022 | 595 | 0.150 |
Why?
|
Botswana | 2 | 2022 | 1018 | 0.150 |
Why?
|
Mother-Child Relations | 1 | 2021 | 488 | 0.150 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2019 | 177 | 0.150 |
Why?
|
Quality-Adjusted Life Years | 3 | 2012 | 1708 | 0.150 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2019 | 227 | 0.150 |
Why?
|
House Calls | 1 | 2019 | 159 | 0.150 |
Why?
|
Proportional Hazards Models | 6 | 2015 | 12455 | 0.150 |
Why?
|
Perinatal Care | 1 | 2020 | 239 | 0.150 |
Why?
|
Single-Blind Method | 1 | 2021 | 1573 | 0.140 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2022 | 1914 | 0.140 |
Why?
|
HIV-1 | 1 | 2014 | 6819 | 0.140 |
Why?
|
Middle Aged | 20 | 2024 | 217039 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6501 | 0.130 |
Why?
|
Psychotherapy, Group | 1 | 2020 | 407 | 0.130 |
Why?
|
Schools | 2 | 2021 | 1449 | 0.130 |
Why?
|
Eating | 2 | 2021 | 1537 | 0.130 |
Why?
|
Bacterial Infections | 1 | 2024 | 1400 | 0.130 |
Why?
|
Postpartum Period | 2 | 2020 | 1160 | 0.130 |
Why?
|
Body Mass Index | 6 | 2020 | 12796 | 0.130 |
Why?
|
Communication Disorders | 1 | 2015 | 49 | 0.130 |
Why?
|
HIV | 1 | 2022 | 1578 | 0.130 |
Why?
|
Anti-Bacterial Agents | 4 | 2024 | 7295 | 0.130 |
Why?
|
School Health Services | 1 | 2019 | 382 | 0.120 |
Why?
|
Motor Skills Disorders | 1 | 2015 | 88 | 0.120 |
Why?
|
Maternal Mortality | 1 | 2017 | 285 | 0.120 |
Why?
|
Research Design | 4 | 2019 | 6113 | 0.120 |
Why?
|
Program Evaluation | 2 | 2023 | 2464 | 0.120 |
Why?
|
Birth Intervals | 1 | 2014 | 51 | 0.120 |
Why?
|
Body Weight | 2 | 2015 | 4605 | 0.120 |
Why?
|
Communicable Disease Control | 1 | 2021 | 843 | 0.120 |
Why?
|
Salaries and Fringe Benefits | 1 | 2016 | 255 | 0.120 |
Why?
|
Community Health Services | 1 | 2019 | 654 | 0.120 |
Why?
|
Lipids | 2 | 2022 | 3329 | 0.120 |
Why?
|
Endemic Diseases | 1 | 2014 | 186 | 0.110 |
Why?
|
Community-Based Participatory Research | 2 | 2019 | 220 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2022 | 872 | 0.110 |
Why?
|
Social Environment | 1 | 2018 | 1010 | 0.110 |
Why?
|
Hepatitis B | 1 | 2019 | 697 | 0.110 |
Why?
|
Sexual Behavior | 2 | 2019 | 2062 | 0.110 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3806 | 0.110 |
Why?
|
Social Class | 1 | 2021 | 1992 | 0.110 |
Why?
|
Inflammation | 3 | 2022 | 10696 | 0.100 |
Why?
|
Antibody Affinity | 1 | 2013 | 245 | 0.100 |
Why?
|
Caregivers | 2 | 2022 | 2172 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 995 | 0.100 |
Why?
|
Maternal Health Services | 1 | 2017 | 441 | 0.100 |
Why?
|
Regression Analysis | 4 | 2016 | 6358 | 0.100 |
Why?
|
Goals | 1 | 2017 | 701 | 0.100 |
Why?
|
Seroepidemiologic Studies | 1 | 2013 | 389 | 0.100 |
Why?
|
Wounds and Injuries | 3 | 2012 | 2427 | 0.100 |
Why?
|
Pneumonia | 2 | 2013 | 2122 | 0.100 |
Why?
|
Fever | 1 | 2019 | 1611 | 0.100 |
Why?
|
Emotions | 3 | 2021 | 2693 | 0.100 |
Why?
|
Delivery, Obstetric | 1 | 2018 | 918 | 0.100 |
Why?
|
Immunocompromised Host | 1 | 2017 | 854 | 0.100 |
Why?
|
Family Planning Services | 1 | 2014 | 258 | 0.100 |
Why?
|
Dehydration | 2 | 2024 | 226 | 0.100 |
Why?
|
Vitamin B Complex | 1 | 2013 | 293 | 0.090 |
Why?
|
Parity | 1 | 2014 | 921 | 0.090 |
Why?
|
Family | 1 | 2021 | 3166 | 0.090 |
Why?
|
Health Surveys | 2 | 2018 | 4010 | 0.090 |
Why?
|
Perinatal Mortality | 1 | 2010 | 99 | 0.090 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2010 | 362 | 0.090 |
Why?
|
Ascorbic Acid | 1 | 2013 | 653 | 0.090 |
Why?
|
Ghana | 2 | 2022 | 309 | 0.090 |
Why?
|
Social Behavior | 1 | 2016 | 1127 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1873 | 0.080 |
Why?
|
Hepatitis C | 1 | 2020 | 1573 | 0.080 |
Why?
|
Infant Food | 2 | 2019 | 141 | 0.080 |
Why?
|
Body Weights and Measures | 2 | 2019 | 208 | 0.080 |
Why?
|
Cluster Analysis | 3 | 2021 | 2683 | 0.080 |
Why?
|
Students | 1 | 2019 | 1667 | 0.080 |
Why?
|
Immunization Schedule | 1 | 2010 | 221 | 0.080 |
Why?
|
Adiposity | 1 | 2019 | 1844 | 0.080 |
Why?
|
Cost-Benefit Analysis | 4 | 2022 | 5481 | 0.080 |
Why?
|
Vitamin E | 1 | 2013 | 872 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2020 | 10796 | 0.070 |
Why?
|
Mortality | 1 | 2019 | 2882 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 2023 | 4518 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2012 | 2935 | 0.070 |
Why?
|
Administration, Inhalation | 1 | 2009 | 1147 | 0.070 |
Why?
|
Cost of Illness | 1 | 2016 | 1912 | 0.070 |
Why?
|
Hospitalization | 2 | 2016 | 10629 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2019 | 3990 | 0.070 |
Why?
|
Disability Evaluation | 1 | 2012 | 1800 | 0.060 |
Why?
|
Respiratory Function Tests | 1 | 2009 | 1669 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 4691 | 0.060 |
Why?
|
Malaria | 1 | 2014 | 1207 | 0.060 |
Why?
|
Health Services Accessibility | 2 | 2019 | 5282 | 0.060 |
Why?
|
Forced Expiratory Volume | 1 | 2009 | 1793 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2019 | 79133 | 0.060 |
Why?
|
Risk Assessment | 3 | 2024 | 23788 | 0.050 |
Why?
|
Interviews as Topic | 2 | 2019 | 2621 | 0.050 |
Why?
|
Learning | 2 | 2021 | 1719 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 195 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2015 | 3970 | 0.050 |
Why?
|
Child Nutrition Sciences | 1 | 2020 | 22 | 0.050 |
Why?
|
Mental Disorders | 1 | 2021 | 6696 | 0.050 |
Why?
|
Isoniazid | 1 | 2022 | 282 | 0.050 |
Why?
|
Aged | 6 | 2022 | 166585 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2009 | 1867 | 0.050 |
Why?
|
Diarrhea, Infantile | 1 | 2020 | 107 | 0.040 |
Why?
|
Acute Disease | 2 | 2021 | 7212 | 0.040 |
Why?
|
Length of Stay | 1 | 2013 | 6372 | 0.040 |
Why?
|
Cause of Death | 1 | 2010 | 3685 | 0.040 |
Why?
|
MEDLINE | 1 | 2019 | 118 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 969 | 0.040 |
Why?
|
Spouses | 1 | 2021 | 274 | 0.040 |
Why?
|
Edema | 1 | 2023 | 770 | 0.040 |
Why?
|
Orosomucoid | 1 | 2018 | 47 | 0.040 |
Why?
|
Weight Gain | 2 | 2019 | 2330 | 0.040 |
Why?
|
Exercise | 3 | 2019 | 5746 | 0.040 |
Why?
|
Food, Fortified | 1 | 2019 | 188 | 0.040 |
Why?
|
Arm | 1 | 2021 | 582 | 0.040 |
Why?
|
Overweight | 2 | 2019 | 2400 | 0.040 |
Why?
|
Nutritional Sciences | 1 | 2019 | 137 | 0.040 |
Why?
|
Colombia | 1 | 2019 | 271 | 0.040 |
Why?
|
Pregnancy in Adolescence | 1 | 2019 | 162 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58299 | 0.040 |
Why?
|
Diet Surveys | 1 | 2021 | 1159 | 0.040 |
Why?
|
Vomiting | 1 | 2020 | 634 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1689 | 0.030 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 415 | 0.030 |
Why?
|
Minerals | 1 | 2017 | 282 | 0.030 |
Why?
|
Trace Elements | 1 | 2017 | 196 | 0.030 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2019 | 542 | 0.030 |
Why?
|
Protoporphyrins | 1 | 2016 | 165 | 0.030 |
Why?
|
Child Behavior | 1 | 2021 | 842 | 0.030 |
Why?
|
Term Birth | 1 | 2016 | 135 | 0.030 |
Why?
|
Economics | 1 | 2016 | 141 | 0.030 |
Why?
|
Health Resources | 1 | 2021 | 920 | 0.030 |
Why?
|
Pregnancy Trimester, First | 1 | 2019 | 902 | 0.030 |
Why?
|
Diet Records | 1 | 2016 | 424 | 0.030 |
Why?
|
Latin America | 1 | 2016 | 402 | 0.030 |
Why?
|
Asia | 1 | 2016 | 614 | 0.030 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2023 | 2197 | 0.030 |
Why?
|
Receptors, Transferrin | 1 | 2016 | 290 | 0.030 |
Why?
|
Family Characteristics | 1 | 2019 | 991 | 0.030 |
Why?
|
Disabled Children | 1 | 2017 | 249 | 0.030 |
Why?
|
Pregnancy, Multiple | 1 | 2015 | 215 | 0.030 |
Why?
|
Databases, Factual | 1 | 2009 | 7897 | 0.030 |
Why?
|
Zinc Sulfate | 1 | 2013 | 18 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2022 | 1361 | 0.030 |
Why?
|
Birth Order | 1 | 2014 | 95 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2017 | 626 | 0.030 |
Why?
|
Placenta | 1 | 2022 | 1688 | 0.030 |
Why?
|
Violence | 1 | 2019 | 921 | 0.030 |
Why?
|
Infant, Premature | 1 | 2023 | 2064 | 0.030 |
Why?
|
United States | 2 | 2019 | 71438 | 0.030 |
Why?
|
Food Supply | 1 | 2019 | 520 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2014 | 507 | 0.030 |
Why?
|
Indonesia | 1 | 2012 | 124 | 0.030 |
Why?
|
Empirical Research | 1 | 2012 | 119 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2019 | 899 | 0.030 |
Why?
|
Attention | 1 | 2022 | 2367 | 0.030 |
Why?
|
Parent-Child Relations | 1 | 2017 | 748 | 0.030 |
Why?
|
Prognosis | 1 | 2013 | 29337 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2019 | 21851 | 0.020 |
Why?
|
Bangladesh | 1 | 2012 | 701 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2021 | 2743 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3117 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 19901 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2013 | 1540 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3915 | 0.020 |
Why?
|
Patient Readmission | 1 | 2023 | 3288 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2131 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2020 | 3174 | 0.020 |
Why?
|
Psychometrics | 1 | 2017 | 3005 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1179 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13277 | 0.020 |
Why?
|
Risk | 1 | 2016 | 9613 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3065 | 0.010 |
Why?
|
Animals | 2 | 2021 | 166811 | 0.010 |
Why?
|
Health Policy | 1 | 2010 | 2656 | 0.010 |
Why?
|